.15e4dc1dd95d816d.png)
Global Collaborative Centre for Medical Countermeasures (GCMC)
TechInvention's Global Collaborative Centre for Medical Countermeasures (GCMC) is an Integrated Full-Cycle Vaccine Development & Manufacturing Facility designed to accelerate the journey from scientific discovery to global health impact.
Developed in alignment with international GMP standards, GCMC brings together vaccine process development, manufacturing scale-up, technology transfer, analytical testing, quality systems, regulatory support, drug product manufacturing, digital innovation, and sustainable infrastructure within one integrated facility.
Scientific innovation begins in research laboratories, universities, and biotechnology companies, but transforming promising discoveries into commercially viable vaccines requires specialized expertise, advanced manufacturing infrastructure, regulatory compliance, and scalable production capabilities.
GCMC bridges this critical gap by providing end-to-end support across vaccine development, process optimization, manufacturing scale-up, technology transfer, GMP manufacturing, quality assurance, and regulatory readiness.
Stockpile for emergency outbreak and pandemic preparedness
Optimised tech packs for seamless transfer and rapid commercialisation
Stockpile for emergency outbreak and pandemic preparedness
Optimised tech packs for seamless transfer and rapid commercialisation
Two flexible upstream manufacturing suites equipped with stainless-steel bioreactor systems (20 L and 100 L), enabling efficient process development, optimization, and manufacturing scale-up across diverse production platforms.
Integrated purification capabilities supporting recovery, concentration, purification, polishing, and process optimization to ensure consistent product quality and manufacturing robustness.
Flexible fill-finish capabilities through a multi-format manufacturing line supporting liquid vials and pre-filled syringes for clinical and commercial supply.
Comprehensive support for analytical development, quality management systems, regulatory documentation, validation, technology transfer, manufacturing readiness, and commercialization planning to enable successful product advancement.
Specialized hands-on training programs in vaccine manufacturing, GMP operations, quality assurance, biosafety, regulatory compliance, and advanced bioprocessing to strengthen global biomanufacturing capacity.
Digital technologies are integrated throughout GCMC to improve process efficiency, manufacturing visibility, operational performance, and product quality. By embedding digital intelligence across research, development, manufacturing, and facility operations, GCMC enables faster decision-making, improved process consistency, enhanced product quality, and operational resilience.
Sustainability is embedded into every aspect of GCMC's design and operations to support responsible and energy-efficient vaccine manufacturing. The facility integrates renewable energy solutions, intelligent building management systems, water conservation strategies, and energy-efficient utilities to reduce environmental impact while maintaining world-class manufacturing performance.
Connect with us to explore manufacturing partnerships in vaccines and partnerships